IBDEI28O ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,35751,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35751,1,3,0)
 ;;=3^Hemiplegia,Unspec Affecting Left Nondominant Side
 ;;^UTILITY(U,$J,358.3,35751,1,4,0)
 ;;=4^G81.94
 ;;^UTILITY(U,$J,358.3,35751,2)
 ;;=^5004124
 ;;^UTILITY(U,$J,358.3,35752,0)
 ;;=G81.91^^139^1822^8
 ;;^UTILITY(U,$J,358.3,35752,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35752,1,3,0)
 ;;=3^Hemiplegia,Unspec Affecting Right Dominant Side
 ;;^UTILITY(U,$J,358.3,35752,1,4,0)
 ;;=4^G81.91
 ;;^UTILITY(U,$J,358.3,35752,2)
 ;;=^5004121
 ;;^UTILITY(U,$J,358.3,35753,0)
 ;;=G81.93^^139^1822^9
 ;;^UTILITY(U,$J,358.3,35753,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35753,1,3,0)
 ;;=3^Hemiplegia,Unspec Affecting Right Nondominant Side
 ;;^UTILITY(U,$J,358.3,35753,1,4,0)
 ;;=4^G81.93
 ;;^UTILITY(U,$J,358.3,35753,2)
 ;;=^5004123
 ;;^UTILITY(U,$J,358.3,35754,0)
 ;;=I69.942^^139^1822^22
 ;;^UTILITY(U,$J,358.3,35754,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35754,1,3,0)
 ;;=3^Monoplg LL after Unsp Crbvasc Dis,Left Dominant Side
 ;;^UTILITY(U,$J,358.3,35754,1,4,0)
 ;;=4^I69.942
 ;;^UTILITY(U,$J,358.3,35754,2)
 ;;=^5133582
 ;;^UTILITY(U,$J,358.3,35755,0)
 ;;=I69.944^^139^1822^23
 ;;^UTILITY(U,$J,358.3,35755,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35755,1,3,0)
 ;;=3^Monoplg LL after Unsp Crbvasc Dis,Left Nondominant Side
 ;;^UTILITY(U,$J,358.3,35755,1,4,0)
 ;;=4^I69.944
 ;;^UTILITY(U,$J,358.3,35755,2)
 ;;=^5133585
 ;;^UTILITY(U,$J,358.3,35756,0)
 ;;=I69.941^^139^1822^24
 ;;^UTILITY(U,$J,358.3,35756,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35756,1,3,0)
 ;;=3^Monoplg LL after Unsp Crbvasc Dis,Right Dominant Side
 ;;^UTILITY(U,$J,358.3,35756,1,4,0)
 ;;=4^I69.941
 ;;^UTILITY(U,$J,358.3,35756,2)
 ;;=^5133581
 ;;^UTILITY(U,$J,358.3,35757,0)
 ;;=I69.943^^139^1822^25
 ;;^UTILITY(U,$J,358.3,35757,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35757,1,3,0)
 ;;=3^Monoplg LL after Unsp Crbvasc Dis,Right Nondominant Side
 ;;^UTILITY(U,$J,358.3,35757,1,4,0)
 ;;=4^I69.943
 ;;^UTILITY(U,$J,358.3,35757,2)
 ;;=^5133584
 ;;^UTILITY(U,$J,358.3,35758,0)
 ;;=G35.^^139^1822^26
 ;;^UTILITY(U,$J,358.3,35758,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35758,1,3,0)
 ;;=3^Multiple sclerosis
 ;;^UTILITY(U,$J,358.3,35758,1,4,0)
 ;;=4^G35.
 ;;^UTILITY(U,$J,358.3,35758,2)
 ;;=^79761
 ;;^UTILITY(U,$J,358.3,35759,0)
 ;;=G20.^^139^1822^27
 ;;^UTILITY(U,$J,358.3,35759,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35759,1,3,0)
 ;;=3^Parkinson's disease
 ;;^UTILITY(U,$J,358.3,35759,1,4,0)
 ;;=4^G20.
 ;;^UTILITY(U,$J,358.3,35759,2)
 ;;=^5003770
 ;;^UTILITY(U,$J,358.3,35760,0)
 ;;=R56.9^^139^1822^3
 ;;^UTILITY(U,$J,358.3,35760,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35760,1,3,0)
 ;;=3^Convulsions,Unspec
 ;;^UTILITY(U,$J,358.3,35760,1,4,0)
 ;;=4^R56.9
 ;;^UTILITY(U,$J,358.3,35760,2)
 ;;=^5019524
 ;;^UTILITY(U,$J,358.3,35761,0)
 ;;=S06.9X5S^^139^1822^14
 ;;^UTILITY(U,$J,358.3,35761,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35761,1,3,0)
 ;;=3^Intcrn injury w LOC >24 hr w ret consc lev, sequela
 ;;^UTILITY(U,$J,358.3,35761,1,4,0)
 ;;=4^S06.9X5S
 ;;^UTILITY(U,$J,358.3,35761,2)
 ;;=^5021223
 ;;^UTILITY(U,$J,358.3,35762,0)
 ;;=S06.9X6S^^139^1822^15
 ;;^UTILITY(U,$J,358.3,35762,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35762,1,3,0)
 ;;=3^Intcrn injury w LOC >24 hr w/o ret consc w surv, sqla
 ;;^UTILITY(U,$J,358.3,35762,1,4,0)
 ;;=4^S06.9X6S
 ;;^UTILITY(U,$J,358.3,35762,2)
 ;;=^5021226
